Roche Holding Financials
| RHO6 Stock | EUR 31.48 1.23 4.07% |
Roche |
Understanding current and past Roche Holding Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Roche Holding's financial statements are interrelated, with each one affecting the others. For example, an increase in Roche Holding's assets may result in an increase in income on the income statement.
The data published in Roche Holding's official financial statements typically reflect Roche Holding's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Roche Holding's quantitative information. For example, before you start analyzing numbers published by Roche accountants, it’s essential to understand Roche Holding's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the presentation of Roche Holding's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Roche Holding's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Roche Holding's management manipulating its earnings.
Roche Holding Stock Summary
Roche Holding competes with Johnson Johnson, Merck, Biogen, and ASTELLAS PHARMA. Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE HLDG operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101465 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US7711951043 |
| Business Address | Konzern Hauptsitz, Basel, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | NYSE Composite |
| Website | www.roche.com |
| Phone | 41 61 688 11 11 |
| Currency | EUR - Euro |
You should never invest in Roche Holding without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Roche Stock, because this is throwing your money away. Analyzing the key information contained in Roche Holding's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Roche Holding Key Financial Ratios
There are many critical financial ratios that Roche Holding's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Roche Holding reports annually and quarterly.| Return On Equity | 0.45 | |||
| Return On Asset | 0.15 | |||
| Target Price | 52.44 | |||
| Beta | 0.19 | |||
| Z Score | 7.8 |
Roche Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Roche Holding's current stock value. Our valuation model uses many indicators to compare Roche Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Roche Holding competition to find correlations between indicators driving Roche Holding's intrinsic value. More Info.Roche Holding Ltd is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Roche Holding Ltd is roughly 3.05 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Roche Holding's earnings, one of the primary drivers of an investment's value.Roche Holding Systematic Risk
Roche Holding's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Roche Holding volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Roche Holding correlated with the market. If Beta is less than 0 Roche Holding generally moves in the opposite direction as compared to the market. If Roche Holding Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Roche Holding is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Roche Holding is generally in the same direction as the market. If Beta > 1 Roche Holding moves generally in the same direction as, but more than the movement of the benchmark.
Roche Holding June 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Roche Holding help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Roche Holding Ltd. We use our internally-developed statistical techniques to arrive at the intrinsic value of Roche Holding Ltd based on widely used predictive technical indicators. In general, we focus on analyzing Roche Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Roche Holding's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.68 | |||
| Information Ratio | 0.0584 | |||
| Maximum Drawdown | 6.63 | |||
| Value At Risk | (2.83) | |||
| Potential Upside | 3.37 |
Complementary Tools for Roche Stock analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |